Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Porter

Showing results (71-80 of 199) with videos related to

Pageof 20
Sort By:
Leukemia & Lymphoma|June 7, 2006
A predictive model for the detection of tumor lysis syndrome during AML induction therapyAnthony R Mato, Brett E Riccio, Li Qin, et al.
American Journal of Hematology|May 21, 2016
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantationClinton Yam, Lisa Crisalli, Selina M Luger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2009
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantationGregory L Beatty, Jasmine S Smith, Ran Reshef, et al.
Blood|March 6, 2014
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cellsSaar Gill, Sarah K Tasian, Marco Ruella, et al.
Leukemia & Lymphoma|January 24, 2024
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantationCraig W Freyer, Alison Carulli, Noelle V Frey, et al.
American Journal of Hematology|September 27, 2008
Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormalityNoelle V Frey, Christopher E Leid, Peter C Nowell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2022
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy StudiesYimei Li, Wei-Ting Hwang, Shannon L Maude, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutritionStephen J Bagley, Alison R Sehgal, Saar Gill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2018
Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated DonorsLisa M Crisalli, Joanne T Hinkle, Christopher C Walling, et al.
Blood|January 7, 2017
Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxisRyan H Moy, Austin P Huffman, Lee P Richman, et al.
Pageof 20

Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|June 7, 2006
A predictive model for the detection of tumor lysis syndrome during AML induction therapyAnthony R Mato, Brett E Riccio, Li Qin, et al.
American Journal of Hematology|May 21, 2016
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantationClinton Yam, Lisa Crisalli, Selina M Luger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2009
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantationGregory L Beatty, Jasmine S Smith, Ran Reshef, et al.
Blood|March 6, 2014
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cellsSaar Gill, Sarah K Tasian, Marco Ruella, et al.
Leukemia & Lymphoma|January 24, 2024
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantationCraig W Freyer, Alison Carulli, Noelle V Frey, et al.
American Journal of Hematology|September 27, 2008
Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormalityNoelle V Frey, Christopher E Leid, Peter C Nowell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2022
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy StudiesYimei Li, Wei-Ting Hwang, Shannon L Maude, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutritionStephen J Bagley, Alison R Sehgal, Saar Gill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2018
Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated DonorsLisa M Crisalli, Joanne T Hinkle, Christopher C Walling, et al.
Blood|January 7, 2017
Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxisRyan H Moy, Austin P Huffman, Lee P Richman, et al.
Pageof 20